The estimated Net Worth of Charles H Sherwood is at least $23.4 Milion dollars as of 24 October 2017. Mr Sherwood owns over 3,278 units of Anika Therapeutics stock worth over $3,220,182 and over the last 21 years he sold ANIK stock worth over $20,194,874.
Mr has made over 26 trades of the Anika Therapeutics stock since 2005, according to the Form 4 filled with the SEC. Most recently he sold 3,278 units of ANIK stock worth $196,811 on 24 October 2017.
The largest trade he's ever made was exercising 337,530 units of Anika Therapeutics stock on 5 May 2014 worth over $2,639,485. On average, Mr trades about 30,007 units every 100 days since 2003. As of 24 October 2017 he still owns at least 132,791 units of Anika Therapeutics stock.
You can see the complete history of Mr Sherwood stock trades at the bottom of the page.
Charles Sherwood III is the VP & Corp. Legal Counsel at Anika Therapeutics.
Over the last 21 years, insiders at Anika Therapeutics have traded over $58,649,775 worth of Anika Therapeutics stock and bought 34,227 units worth $758,329 . The most active insiders traders include Charles H Sherwood, Farmaceutici S.P.A. Fidia oraz Joseph H Capper. On average, Anika Therapeutics executives and independent directors trade stock every 47 days with the average trade being worth of $613,258. The most recent stock trade was executed by Cheryl R Blanchard on 11 March 2024, trading 64,480 units of ANIK stock currently worth $1,563,640.
who we are we are anika therapeutics, a global medical technology company at the forefront of pain management, tissue regeneration and wound healing. we are committed to delivering innovative medical solutions that help patients feel better faster, look and feel younger and remain active. with over 7 million procedures performed over the past twenty years utilizing our proprietary technology, anika is helping individuals all over the world return to life naturally. our guiding principles we are innovators and creators. we value strong discipline and exceptional focus from our personnel, and we employ lean principles and agile processes in managing our business. this foundation of guiding values, combined with our entrepreneurial spirit, gives anika the ability and fortitude to generate innovative ideas and to grow our portfolio of successful products. what we do anika offers a broad spectrum of therapeutic treatments ranging from pain management and tissue regeneration to wound care an
Anika Therapeutics executives and other stock owners filed with the SEC include: